Press Releases

Press Releases

Press Releases
04.29.24
Libervant is the first and only FDA approved orally administered rescue product for the treatment of seizure clusters in patients ages 2 to 5 Announces immediate availability of Libervant 5mg, 7.5mg, 10mg, 12.5mg, and 15mg for patients between 2 to 5 years of age Company track record now includes 4
Displaying 1 - 10 of 19
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds